Altered Transcriptome of the B. melitensis Vaccine Candidate 16MΔvjbR, Implications for Development of Genetically Marked Live Vaccine

[1]  Yufei Wang,et al.  The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection. , 2011, Veterinary microbiology.

[2]  J. Lemaire,et al.  Global Analysis of Quorum Sensing Targets in the Intracellular Pathogen Brucella melitensis 16 M , 2010, Journal of Proteome Research.

[3]  Xinghong Yang,et al.  DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate. , 2010, Vaccine.

[4]  H. Garner,et al.  Brucella melitensis VjbR and C12-HSL regulons: contributions of the N-dodecanoyl homoserine lactone signaling molecule and LuxR homologue VjbR to gene expression , 2010, BMC Microbiology.

[5]  Ruifu Yang,et al.  Comparative Proteomics Analyses Reveal the virB of B. melitensis Affects Expression of Intracellular Survival Related Proteins , 2009, PloS one.

[6]  I. Moriyón,et al.  Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. , 2006, Vaccine.

[7]  E. Cascales,et al.  Biogenesis, architecture, and function of bacterial type IV secretion systems. , 2005, Annual review of microbiology.

[8]  Ruifu Yang,et al.  Transcriptome analysis of the Mg2+-responsive PhoP regulator in Yersinia pestis. , 2005, FEMS microbiology letters.

[9]  J. Letesson,et al.  A quorum‐sensing regulator controls expression of both the type IV secretion system and the flagellar apparatus of Brucella melitensis , 2005, Cellular microbiology.

[10]  R. Roop,et al.  Intact Purine Biosynthesis Pathways Are Required for Wild-Type Virulence of Brucella abortus 2308 in the BALB/c Mouse Model , 2004, Infection and Immunity.

[11]  A. Cloeckaert,et al.  Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. , 2004, Vaccine.

[12]  Z. Memish,et al.  Brucellosis and international travel. , 2004, Journal of travel medicine.

[13]  E. Moreno,et al.  Rough vaccines in animal brucellosis: structural and genetic basis and present status. , 2004, Veterinary research.

[14]  Nammalwar Sriranganathan,et al.  Brucellosis vaccines: past, present and future. , 2002, Veterinary microbiology.

[15]  R. Ugalde,et al.  Brucella abortus Cyclic β-1,2-Glucan Mutants Have Reduced Virulence in Mice and Are Defective in Intracellular Replication in HeLa Cells , 2001, Infection and Immunity.

[16]  D. O’Callaghan,et al.  Brucellosis: a worldwide zoonosis. , 2001, Current opinion in microbiology.

[17]  P. Christie,et al.  Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells. , 2000, Trends in microbiology.

[18]  A. Cloeckaert,et al.  Characterization of Heat, Oxidative, and Acid Stress Responses in Brucella melitensis , 2000, Infection and Immunity.

[19]  J. Blasco,et al.  A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. , 1997, Preventive veterinary medicine.

[20]  C. Gamazo,et al.  An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination. , 1992, Veterinary microbiology.

[21]  P. Nicoletti Vaccination against Brucella. , 1990, Advances in biotechnological processes.